TD Asset Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

TD Asset Management’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-31,090	Closed	-$418K	–	1492
2020 Q3	$418K	Hold	31,090	–	–	﹤0.01%	1282
2020 Q2	$1.32M	Buy	31,090 +1,100	+4%	+$35.6K	﹤0.01%	980
2020 Q1	$828K	Hold	29,990	–	–	﹤0.01%	1047
2019 Q4	$973K	Hold	29,990	–	–	﹤0.01%	1100
2019 Q3	$781K	Buy	29,990 +1,597	+6%	+$53.4K	﹤0.01%	1102
2019 Q2	$1.04M	Buy	28,393 +10,331	+57%	+$248K	﹤0.01%	1041
2019 Q1	$399K	Buy	18,062 +100	+0.6%	+$1.75K	﹤0.01%	1227
2018 Q4	$253K	Buy	17,962 +6,793	+61%	+$106K	﹤0.01%	1327
2018 Q3	$217K	Buy	+11,169	New	+$228K	﹤0.01%	1399

Other funds holding ODT

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

TD Asset Management's ODT Position: Q4 2020 in Review

TD Asset Management sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q4 2020, closing a stake of 31,090 shares — an estimated $418K sold.

TD Asset Management first reported a position in ODT in Q3 2018 and held it in 9 quarters. The position peaked at $1.32M in Q2 2020. 94 funds tracked by Wall St. Rank hold ODT as of Q4 2020.

TD Asset Management reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
TD Asset Management sold 31,090 Odonate Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $418K.
TD Asset Management first reported a position in Odonate Therapeutics, Inc. Common Stock in Q3 2018 and held it in 9 quarters.
TD Asset Management's Odonate Therapeutics, Inc. Common Stock position peaked at $1.32M in Q2 2020.
94 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q4 2020.

Based on TD Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.